J M Connors

Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor.

B Friedman, A. Raymond Frackelton, Alonzo H. Ross et al. · Proceedings of the National Academy of Sciences · 1984 · 218 citations · Full text

Medicine, Oncology, Pharmacology +17

Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.

Donna Reece, Michael J. Barnett, J M Connors et al. · Journal of Clinical Oncology · 1991 · 176 citations

Medicine, Oncology, Pharmacology +16

MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.

Paul Klimo, J M Connors · Journal of Clinical Oncology · 1985 · 174 citations

Medicine, Oncology, Pharmacotherapy +10

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.

Bruce D. Cheson, John M. Sorensen, D. Vena et al. · Journal of Clinical Oncology · 1998 · 156 citations

Medicine, Oncology, Pharmacology +8

Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy.

Siân Jones, Thomas P. Miller, J M Connors · Journal of Clinical Oncology · 1989 · 123 citations

Medicine, Oncology, Chemotherapy +13